Kazuki Takada
Impact in
- Rheumatology top 0.5%
- Systemic Lupus Erythematosus Research
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- Inflammatory Biomarkers in Disease Prognosis
Papers in
- Oncology 55
- Cancer Immunotherapy and Biomarkers 32
- Lung Cancer Research Studies 11
- Inflammatory Biomarkers in Disease Prognosis 10
-
- Lung Cancer Treatments and Mutations 15
- Lung Cancer Diagnosis and Treatment 7
- Co-authors
- Yoshihiko Maehara (53 shared papers)Tatsuro Okamoto (50 shared papers)Shinkichi Takamori (58 shared papers)Gouji Toyokawa (53 shared papers)Gabor G. Illei (7 shared papers)Fumihiro Shoji (33 shared papers)Takaki Akamine (45 shared papers)Yoshinao Oda (48 shared papers)
- Journals
- Anticancer Research (14 papers)Annals of Surgical Oncology (10 papers)PLoS ONE (7 papers)Lung Cancer (7 papers)Clinical Lung Cancer (7 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Kazuki Takada
138 papers receiving 4.3k citations
Kazuki Takada's Hit Papers
Peers
Comparison fields: 5 of 114
- Rheumatology 1.2k
- Oncology 1.5k
- Immunology 918
- Biological Psychiatry 88
- Nephrology 199
Countries citing papers authored by Kazuki Takada
This map shows the geographic impact of Kazuki Takada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuki Takada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuki Takada more than expected).
Fields of papers citing papers by Kazuki Takada
This network shows the impact of papers produced by Kazuki Takada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuki Takada. The network helps show where Kazuki Takada may publish in the future.
Co-authors
The 25 scholars most cited alongside Kazuki Takada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 150 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tocilizumab in systemic lupus erythematosus: Data on safety, preliminary efficacy, and impact on circulating plasma cells from an open‐label phase I dosage‐escalation study Hit paper breakdown → | 2010 | 412 |
| 2 | 2002 | 260 | |
| 3 | 2006 | 213 | |
| 4 | 2016 | 159 | |
| 5 | 2003 | 134 | |
| 6 | 2004 | 133 | |
| 7 | 2005 | 116 | |
| 8 | 2009 | 105 | |
| 9 | 2009 | 102 | |
| 10 | 2007 | 96 | |
| 11 | 2016 | 91 | |
| 12 | 2017 | 75 | |
| 13 | 2001 | 74 | |
| 14 | 2021 | 71 | |
| 15 | 2017 | 71 | |
| 16 | 2017 | 64 | |
| 17 | 2017 | 63 | |
| 18 | 2016 | 63 | |
| 19 | 2007 | 63 | |
| 20 | 2006 | 62 |
About Kazuki Takada
Kazuki Takada is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Rheumatology, Molecular Biology and Surgery, having authored 150 papers that have together received 4.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (32 papers), Lung Cancer Treatments and Mutations (15 papers), Systemic Lupus Erythematosus Research (11 papers), Lung Cancer Research Studies (11 papers), Inflammatory Biomarkers in Disease Prognosis (10 papers), Lung Cancer Diagnosis and Treatment (7 papers), Inflammatory Myopathies and Dermatomyositis (6 papers) and Tryptophan and brain disorders (5 papers). The work is most often cited by research in Rheumatology (1.2k citations), Oncology (1.5k citations), Immunology (918 citations), Biological Psychiatry (88 citations) and Nephrology (199 citations). Kazuki Takada has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Yoshihiko Maehara, Tatsuro Okamoto, Shinkichi Takamori, Gouji Toyokawa, Gabor G. Illei, Fumihiro Shoji, Takaki Akamine, Yoshinao Oda, Cheryl Yarboro and Nobuyuki Miyasaka. Their work appears in journals such as Anticancer Research, Annals of Surgical Oncology, PLoS ONE, Lung Cancer and Clinical Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.